An endothelial link between the benefits of physical exercise in dementia

Journal of Cerebral Blood Flow and Metabolism

Volumn 37, Issue 8, 2017, Pages 2649-2664

  Trigiani, Lianne J ^a   Hamel, Edith ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer s; dementia; endothelium; exercise; vascular cognitive impairment

Indexed keywords

AMYLOID BETA PROTEIN; CYCLOOXYGENASE 2; GAMMA1B INTERFERON; GLYCOGEN SYNTHASE KINASE 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SIRTUIN 3; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; DEMENTIA; ENDOTHELIUM CELL; EXERCISE; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; NERVOUS SYSTEM INFLAMMATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; REVIEW; RISK FACTOR; SLEEP QUALITY; WHITE MATTER; ANIMAL; BRAIN CIRCULATION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COGNITION; COMPLICATION; DIABETIC COMPLICATION; LIFESTYLE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; COGNITION; DEMENTIA; DIABETES COMPLICATIONS; EXERCISE; HUMANS; LIFE STYLE; RISK FACTORS;

EID: 85026356122     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X17714655     Document Type: Review

References (160)

1. Wiesmann M, Kiliaan AJ, Claassen JA. Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab 2013; 33: 1696–1706.
2. Iadecola C. The pathobiology of vascular dementia. Neuron 2013; 80: 844–866.
3. Jellinger KA. Pathology and pathogenesis of vascular cognitive impairment – a critical update. Front Aging Neurosci 2013; 5: 1–19.
4. Attems J, Jellinger K, Thal DR. Review: sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 2011; 37: 75–93.
5. Roher AE, Esh C, Rahman A. Atherosclerosis of cerebral arteries in Alzheimer disease. Stroke 2004; 35: 2623–2627.
6. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat Rev Neurosci 2011; 12: 723–738.
7. Storkebaum E, Quaegebeur A, Vikkula M. Cerebrovascular disorders: molecular insights and therapeutic opportunities. Nat Neurosci 2011; 14: 1390–1397.
8. de la Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002; 33: 1152–1162.
9. Barnes DE, Yaffe K, Satariano WA. A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults. J Am Geriatr Soc 2003; 51: 459–465.
10. Smiley-Oyen AL, Lowry KA, Francois SJ. Exercise, fitness, and neurocognitive function in older adults: the “selective improvement” and “cardiovascular fitness” hypotheses. Ann Behav Med 2008; 36: 280–291.
11. Smith PJ, Blumenthal JA, Hoffman BM. Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom Med 2010; 72: 239–252.
12. Holthoff VA, Marschner K, Scharf M. Effects of physical activity training in patients with Alzheimer’s dementia: results of a pilot RCT study. PLoS One 2015; 10: e0121478.
13. Yang SY, Shan CL, Qing H. The effects of aerobic exercise on cognitive function of Alzheimer’s disease patients. CNS Neurol Disord Drug Targets 2015; 14: 1292–1297.
14. Hoffmann K, Sobol NA, Frederiksen KS. Moderate-to-high intensity physical exercise in patients with Alzheimer’s disease: a randomized controlled trial. J Alzheimer’s Dis 2015; 50: 443–453.
15. Ngandu T, Lehtisalo J, Solomon A. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 2015; 385: 2255–2263.
16. Garcia-Mesa Y, Lopez-Ramos JC, Gimenez-Llort L. Physical exercise protects against Alzheimer’s disease in 3xTg-AD mice. J Alzheimer's Dis 2011; 24: 421–454.
17. Dao AT, Zagaar MA, Alkadhi KA. Moderate treadmill exercise protects synaptic plasticity of the dentate gyrus and related signaling cascade in a rat model of Alzheimer’s disease. Mol Neurobiol 2015; 52: 1067–1076.
18. Maesako M, Uemura K, Kubota M. Exercise is more effective than diet control in preventing high fat diet-induced beta-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice. J Biol Chem 2012; 287: 23024–23033.
19. Belarbi K, Burnouf S, Fernandez-Gomez FJ. Beneficial effects of exercise in a transgenic mouse model of Alzheimer’s disease-like tau pathology. Neurobiol Dis 2011; 43: 486–494.
20. Bo H, Kang W, Jiang N. Exercise-induced neuroprotection of hippocampus in APP/PS1 transgenic mice via upregulation of mitochondrial 8-oxoguanine DNA glycosylase. Oxid Med Cell Longev 2014. 2014: 1–14.
21. Souza LC, Filho CB, Goes AT. Neuroprotective effect of physical exercise in a mouse model of Alzheimer’s disease induced by beta-amyloid1-40 peptide. Neurotox Research 2013; 24: 148–163.
22. Mangialasche F, Solomon A, Winblad B. Alzheimer’s disease: clinical trials and drug development. Lancet Neurol 2010; 9: 702–716.
23. Larson EB, Yaffe K, Langa KM. New insights into the dementia epidemic. N Engl J Med 2013; 369: 2275–2277.
24. Bherer L, Erickson KI, Liu-Ambrose T. A review of the effects of physical activity and exercise on cognitive and brain functions in older adults. J Aging Res 2013. 2013: 1–8.
25. Brown BM, Peiffer JJ, Martins RN. Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer’s disease? Mol Psychiatry 2013; 18: 864–874.
26. Paillard T, Rolland Y, de Souto Barreto P. Protective effects of physical exercise in Alzheimer’s disease and Parkinson’s disease: a narrative review. J Clin Neurol 2015; 11: 212–219.
27. Lange-Asschenfeldt C, Kojda G. Alzheimer’s disease, cerebrovascular dysfunction and the benefits of exercise: from vessels to neurons. Exp Gerontol 2008; 43: 499–504.
28. Nishijima T, Torres-Aleman I, Soya H. Exercise and cerebrovascular plasticity. Prog Brain Res 2016; 225: 243–268.
29. Di Francescomarino S, Sciartilli A, Di Valerio V. The effect of physical exercise on endothelial function. Sports Med 2009; 39: 797–812.
30. Leasure JL, Jones M. Forced and voluntary exercise differentially affect brain and behavior. Neuroscience 2008; 156: 456–465.
31. Ke Z, Yip SP, Li L. The effects of voluntary, involuntary, and forced exercises on brain-derived neurotrophic factor and motor function recovery: a rat brain ischemia model. PLoS One 2011; 6: e16643.
32. Povova J, Ambroz P, Bar M. Epidemiological of and risk factors for Alzheimer’s disease: a review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2012; 156: 108–114.
33. Mielke MM, Rosenberg PB, Tschanz J. Vascular factors predict rate of progression in Alzheimer disease. Neurology 2007; 69: 1850–1858.
34. Hadi HAR, Carr CS, Al Suwaidi J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. J Vasc Health Risk Manag 2005; 1: 183–198.
35. Pittilo RM. Cigarette smoking, endothelial injury and cardiovascular disease. Cardiovasc Pathol 2000; 81: 219–230.
36. Mayet J, Hughes A. Cardic and vascular pathophysiology in hypertension. Heart Rhythm 2003; 89: 1104–1109.
37. Dokken BB. The pathophysiology of cardiovascular disease and diabetes: beyond blood pressure and lipids. Diabetes Spectr 2008; 21: 160–165.
38. Cheng Z, Yang X, Wang H. Hyperhomocysteinemia and endothelial dysfunction. Curr Hypertens Rev 2009; 5: 158–165.
39. Stapleton PA, Goodwill AG, James ME. Hypercholesterolemia and microvascular dysfunction: interventional strategies. J Inflam 2010; 7: 1–10.
40. Stokes KY. Microvascular responses to hypercholesterolemia: the interactions between innate and adaptive immune responses. Antioxid Redox Signal 2006; 8: 1141–1151.
41. Ishii M, Iadecola C. Adipocyte-derived factors in age-related dementia and their contribution to vascular and Alzheimer pathology. Biochim Biophys Acta 2016; 1862: 966–974.
42. Hambrecht R, Fiehn E, Weigl C. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 1998; 98: 2709–2715.
43. Hambrecht R, Adams V, Erbs S. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 2003; 107: 3152–3158.
44. Porter VR, Buxton WG, Avidan AY. Sleep, cognition and dementia. Curr Psychiatry Rep 2015; 17: 1–11.
45. Yaffe K, Falvey CM, Hoang T. Connections between sleep and cognition in older adults. Lancet Neurol 2014; 13: 1017–1028.
46. Pace-Schott EF, Spencer RM. Age-related changes in the cognitive function of sleep. Prog Brain Res 2011; 191: 75–89.
47. Daulatzai MA. Evidence of neurodegeneration in obstructive sleep apnea: relationship between obstructive sleep apnea and cognitive dysfunction in the elderly. J Neurosci Res 2015; 93: 1778–1794.
48. Cricco M, Simonsick EM, Foley DJ. The impact of insomnia on cognitive functioning in older adults. J Am Geriatr Soc 2001; 49: 1185–1189.
49. Jessen NA, Munk AS, Lundgaard I. The glymphatic system: a beginner’s guide. Neurochem Res 2015; 40: 2583–2599.
50. Iliff JJ, Chen MJ, Plog BA. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci 2014; 34: 16180–16193.
51. Preston SD, Steart PV, Wilkinson A. Capillary and arterial cerebral amyloid angiopathy in Alzheimer’s disease: defining the perivascular route for the elimination of amyloid β from the human brain. Neuropathol Appl Neurobiol 2003; 29: 106–117.
52. Tarasoff-Conway JM, Carare RO, Osorio RS. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol 2015; 11: 457–470.
53. Jin B-J, Smith AJ, Verkman AS. Spatial model of convective solute transport in brain extracellular space does not support a “glymphatic” mechanism. J Gen Physiol 2016; 148: 489–501.
54. Kim H, Yun CH, Thomas RJ. Obstructive sleep apnea as a risk factor for cerebral white matter change in a middle-aged and older general population. Sleep 2013; 36: 709–715B.
55. Pantano P, Baron J-C, Lebrun-Grandie P. Regional cerebral blood flow and oxygen consumption in human aging. Stroke 1984; 15: 635–641.
56. Capone C, Faraco G, Coleman C. Endothelin 1-dependent neurovascular dysfunction in chronic intermittent hypoxia. Hypertension 2012; 60: 106–113.
57. Driver HS, Taylor SR. Exercise and sleep. Sleep Med Rev 2000; 4: 387–402.
58. Passos GS, Poyares D, Santana MG. Effects of moderate aerobic exercise training on chronic primary insomnia. Sleep Med 2011; 12: 1018–1027.
59. Richards KC, Lambert C, Beck CK. Strength training, walking, and social activity improve sleep in nursing home and assisted living residents: randomized controlled trial. J Am Geriatr Soc 2011; 59: 214–223.
60. Kline CE, Crowley EP, Ewing GB. The effect of exercise training on obstructive sleep apnea and sleep quality: a randomized controlled trial. Sleep 2011; 34: 1631–1640.
61. Lei M, Xu H, Li Z. Soluble Abeta oligomers impair hippocampal LTP by disrupting glutamatergic/GABAergic balance. Neurobiol Dis 2015; 85: 111–121.
62. Tong XK, Nicolakakis N, Fernandes P. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice. Neurobiol Dis 2009; 35: 406–414.
63. Kanekiyo T, Bu G. The low-density lipoprotein receptor-related protein 1 and amyloid-beta clearance in Alzheimer’s disease. Front Aging Neurosci 2014; 6: 1–12.
64. Herring A, Yasin H, Ambree O. Environmental enrichment counteracts Alzheimer’s neurovascular dysfunction in TgCRND8 mice. Brain Pathol 2008; 18: 32–39.
65. Sagare AP, Bell RD, Zlokovic BV. Neurovascular defects and faulty amyloid-beta vascular clearance in Alzheimer’s disease. J Alzheimer’s Dis 2013; 33: 1–21.
66. Koike MA, Green KN, Blurton-Jones M. Oligemic hypoperfusion differentially affects tau and amyloid-{beta}. Am J Pathol 2010; 177: 300–310.
67. Ide K, Secher NH. Cerebral blood flow and metabolism during exercise. Prog Neurobiol 2000; 61: 397–414.
68. Ogoh S, Ainslie PN. Cerebral blood flow during exercise: mechanisms of regulation. J Appl Physiol (1985) 2009; 107: 1370–1380.
69. Querido JS, Sheel AW. Regulation of cerebral blood flow during exericse. Sports Med 2007; 37: 765–782.
70. Austin SA, Katusic ZS. Loss of endothelial nitric oxide synthase promotes p25 generation and tau phosphorylation in a murine model of Alzheimer’s disease. Circ Res 2016; 119: 1128–1134.
71. Yuede CM, Zimmerman SD, Dong H. Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer’s disease. Neurobiol Dis 2009; 35: 426–432.
72. Liu HL, Zhao G, Zhang H. Long-term treadmill exercise inhibits the progression of Alzheimer’s disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice. Behav Brain Res 2013; 256: 261–272.
73. Ohia-Nwoko O, Montazari S, Lau YS. Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice. Mol Neurodegener 2014; 9: 1–17.
74. McCaslin AF, Chen BR, Radosevich AJ. In vivo 3D morphology of astrocyte-vasculature interactions in the somatosensory cortex: implications for neurovascular coupling. J Cereb Blood Flow Metab 2011; 31: 795–806.
75. Lin AL, Zheng W, Halloran JJ. Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer’s disease. J Cereb Blood Flow Metab 2013; 33: 1412–1421.
76. Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 2001; 280: C719–C741.
77. Tang X, Luo YX, Chen HZ. Mitochondria, endothelial cell function, and vascular diseases. Front Physiol 2014; 5: 1–17.
78. Tong XK, Nicolakakis N, Kocharyan A. Vascular remodeling versus amyloid beta-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer’s disease. J Neurosci 2005; 25: 11165–11174.
79. Freeman LR, Keller JN. Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions. Biochim Biophys Acta 2012; 1822: 822–829.
80. Rojas Vega S, Knicker A, Hollmann W. Effect of resistance exercise on serum levels of growth factors in humans. Horm Metab Res 2010; 42: 982–986.
81. Cotman CW, Berchtold NC, Christie LA. Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 2007; 30: 464–472.
82. Chen XL, Dodd G, Thomas S. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol Heart Circ Physiol 2006; 290: H1862–H1870.
83. Miyamoto N, Maki T, Pham LD. Oxidative stress interferes with white matter renewal after prolonged cerebral hypoperfusion in mice. Stroke 2013; 44: 3516–3521.
84. Park L, Anrather J, Zhou P. NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J Neurosci 2005; 25: 1769–1777.
85. Kojda G, Hambrecht R. Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res 2005; 67: 187–197.
86. Blasko I, Stampfer-Kountchev M, Robatscher P. How chronic inflammation can affect the brain and support the development of Alzheimer’s disease in old age: the role of microglia and astrocytes. Aging Cell 2004; 3: 169–176.
87. Medeiros R, LaFerla FM. Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony. Exp Neurol 2013; 239: 133–138.
88. Heneka MT, Golenbock DT, Latz E. Innate immunity in Alzheimer’s disease. Nat Immunol 2015; 16: 229–236.
89. Solito E, Sastre M. Microglia function in Alzheimer’s disease. Front Pharmacol 2012; 3: 1–10.
90. Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 2011; 31: 986–1000.
91. Sandoo A, Veldhuijzen van Zanten JJCS, Metsios GS. The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J 2010; 4: 302–312.
92. Konsman JP, Drukarch B, Van Dam AM. (Peri)vascular production and action of pro-inflammatory cytokines in brain pathology. Clin Sci (Lond) 2007; 112: 1–25.
93. Faraco G, Sugiyama Y, Lane D. Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension. J Clin Invest 2016; 126: 4674–4689.
94. Bell RD, Zlokovic BV. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer’s disease. Acta Neuropathol 2009; 118: 103–113.
95. Perry VH. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun 2004; 18: 407–413.
96. Pietronigro E, Zenaro E, Constantin G. Imaging of leukocyte trafficking in Alzheimer’s disease. Front Immunol 2016; 7: 1–11.
97. Meyer-Luehmann M, Prinz M. Myeloid cells in Alzheimer’s disease: culprits, victims or innocent bystanders? Trends Neurosci 2015; 38: 659–668.
98. Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 2007; 7: 803–815.
99. Pate M, Damarla V, Chi DS, et al. Endothelial cell biology: Role in the inflammatory response. Adv Clin Chem. 2010; 52: 109–130
100. Lee J, Cho JY, Kim WK. Anti-inflammation effect of Exercise and Korean red ginseng in aging model rats with diet-induced atherosclerosis. Nutr Res Pract 2014; 8: 284–291.
101. Palmer TD, Willhoite AR, Gage FH. Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 2000; 425: 479–494.
102. Leroy K, Yilmaz Z, Brion JP. Increased level of active GSK-3beta in Alzheimer’s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol 2007; 33: 43–55.
103. Libro R, Bramanti P, Mazzon E. The role of the Wnt canonical signaling in neurodegenerative diseases. Life Sci 2016; 158: 78–88.
104. Zhang L, Yang X, Yang S. The Wnt /beta-catenin signaling pathway in the adult neurogenesis. Eur J Neurosci 2011; 33: 1–8.
105. Otsuka F, Finn AV, Yazdani SK. The importance of the endothelium in atherothrombosis and coronary stenting. Nat Rev Cardiol 2012; 9: 439–453.
106. Ferreri DM, Minnear FL, Yin T. N-cadherin levels in endothelial cells are regulated by monolayer maturity and p120 availability. Cell Commun Adhes 2008; 15: 333–349.
107. Nakahashi T, Fujimura H, Altar CA. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 2000; 470: 113–117.
108. Hock C, Heese K, Hulette C. Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 2000; 57: 846–851.
109. Lee J, Fukumoto H, Orne J. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms. Exp Neurol 2005; 194: 91–96.
110. Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors 2004; 22: 123–131.
111. Miyamoto N, Maki T, Shindo A. Astrocytes promote oligodendrogenesis after white matter damage via brain-derived neurotrophic factor. J Neurosci 2015; 35: 14002–14008.
112. Intlekofer KA, Cotman CW. Exercise counteracts declining hippocampal function in aging and Alzheimer’s disease. Neurobiol Dis 2013; 57: 47–55.
113. Nichol K, Deeny SP, Seif J. Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice. Alzheimer’s Dement 2009; 5: 287–294.
114. Garcia-Mesa Y, Pareja-Galeano H, Bonet-Costa V. Physical exercise neuroprotects ovariectomized 3xTg-AD mice through BDNF mechanisms. Psychoneuroendocrinology 2014; 45: 154–166.
115. Um HS, Kang EB, Koo JH. Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer’s disease. Neurosci Res 2011; 69: 161–173.
116. Koutsakis C, Kazanis I. How necessary is the vasculature in the life of neural stem and progenitor cells? Evidence from evolution, development and the adult nervous system. Front Cell Neurosci 2016; 10: 1–7.
117. Kermani P, Hempstead B. BDNF: a newly described mediator of angiogenesis. Trends Cardiovasc Med 2007; 17: 140–143.
118. Zerlin M, Julius MA, Kitajewski J. Wnt/Frizzled signaling in angiogenesis. Angiogenesis 2008; 11: 63–69.
119. Papetti M, Herman IM. Mechanisms of normal and tumor-derived angiogenesis. Cell Physiol 2002; 282: C947–C970.
120. Ogunshola OO, Stewart WB, Mihalcik V. Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Dev Brain Res 2000; 119: 139–153.
121. Lee ST, Chu K, Jung KH. Reduced circulating angiogenic cells in Alzheimer disease. Neurology 2009; 72: 1858–1863.
122. Rehman J, Li J, Parvathaneni L. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol 2004; 43: 2314–2318.
123. Huang L, Jia J, Liu R. Decreased serum levels of the angiogenic factors VEGF and TGF-beta1 in Alzheimer’s disease and amnestic mild cognitive impairment. Neurosci Lett 2013; 550: 60–63.
124. Nozaki H, Nishizawa M, Onodera O. Features of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 2014; 45: 3447–3453.
125. Bullitt E, Rahman FN, Smith JK. The effect of exercise on the cerebral vasculature of healthy aged subjects as visualized by MR angiography. AJNR Am J Neuroradiol 2009; 30: 1857–1863.
126. Swain RA, Harris AB, Wiener EC. Prolonged exercise induces angiogenesis and increases cerebral blood volume in primary motor cortex of the rat. Neuroscience 2003; 117: 1037–1046.
127. Zhang P, Yu H, Zhou N. Early exercise improves cerebral blood flow through increased angiogenesis in experimental stroke rat model. J Neuroeng Rehabil 2013; 10: 1–10.
128. Dalsgaard MK, Volianitis S, Yoshiga CC. Cerebral metabolism during upper and lower body exercise. J Appl Physiol (1985) 2004; 97: 1733–1739.
129. Lecrux C, Hamel E. The neurovascular unit in brain function and disease. Acta Physiol (Oxf) 2011; 203: 47–59.
130. Uysal N, Kiray M, Sisman AR. Effects of voluntary and involuntary exercise on cognitive functions, and VEGF and BDNF levels in adolescent rats. Biotech Histochem 2015; 90: 55–68.
131. Dominguez RO, Pagano MA, Marschoff ER. Alzheimer disease and cognitive impairment associated with diabetes mellitus type 2: associations and a hypothesis. Neurologia (Barcelona, Spain) 2014; 29: 567–572.
132. Sanabria-Diaz G, Martinez-Montes E, Melie-Garcia L. Glucose metabolism during resting state reveals abnormal brain networks organization in the Alzheimer’s disease and mild cognitive impairment. PLoS One 2013; 8: e68860.
133. Macdonald IR, DeBay DR, Reid GA. Early detection of cerebral glucose uptake changes in the 5XFAD mouse. Curr Alzheimer Res 2014; 11: 450–460.
134. Winkler EA, Nishida Y, Sagare AP. GLUT1 reductions exacerbate Alzheimer’s disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci 2015; 18: 521–530.
135. Park S, Jang JS, Jun DW. Exercise enhances insulin and leptin signaling in the cerebral cortex and hypothalamus during dexamethasone-induced stress in diabetic rats. Neuroendocrinology 2005; 82: 282–293.
136. Baker LD, Frank LL, Foster-Schubert K. Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch Neurol 2010; 67: 71–79.
137. Takimoto M, Hamada T. Acute exercise increases brain region-specific expression of MCT1, MCT2, MCT4, GLUT1, and COX IV proteins. J Appl Physiol (1985) 2014; 116: 1238–1250.
138. Huanga Y, Leia L, Liua D-G. Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1α–dependent function. Proc Natl Acad Sci U S A 2012; 109: 17478–17483.
139. Zheng C, Liu Z. Vascular function, insulin action, and exercise: an intricate interplay. Trends Endocrinol Metab 2015; 26: 297–304.
140. Bouallegue A, Daou GB, Srivastava AK. Endothelin-1-induced signaling pathways in vascular smooth muscle cells. Curr Vasc Pharmacol 2007; 5: 45–52.
141. Zarei M, Damoiseaux JS, Morgese C. Regional white matter integrity differentiates between vascular dementia and Alzheimer disease. Stroke 2009; 40: 773–779.
142. Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol 2015; 11: 157–165.
143. Gerrish AC, Thomas AG, Dineen RA. Brain white matter tracts: functional anatomy and clinical relevance. Semin Ultrasound CT MR 2014; 35: 432–444.
144. Fields RD. White matter in learning, cognition and psychiatric disorders. Trends Neurosci 2008; 31: 361–370.
145. Lacalle-Aurioles M, Navas-Sanchez FJ, Aleman-Gomez Y. The disconnection hypothesis in Alzheimer’s disease studied through multimodal magnetic resonance imaging: structural, perfusion, and diffusion tensor imaging. J Alzheimer’s Dis 2016; 50: 1051–1064.
146. Nonaka H, Akima M, Hatori T. The microvasculature of the cerebral white matter: arteries of the subcortical white matter. J Neuropathol Exp Neurol 2003; 62: 154–161.
147. Chaddock-Heyman L, Erickson KI, Holtrop JL. Aerobic fitness is associated with greater white matter integrity in children. Front Hum Neurosci 2014; 8: 1–7.
148. Herting MM, Colby JB, Sowell ER. White matter connectivity and aerobic fitness in male adolescents. Dev Cogn Neurosci 2014; 7: 65–75.
149. Marks BL, Katz LM, Styner M. Aerobic fitness and obesity: relationship to cerebral white matter integrity in the brain of active and sedentary older adults. Br J Sports Med 2011; 45: 1208–1215.
150. Hayes SM, Salat DH, Forman DE. Cardiorespiratory fitness is associated with white matter integrity in aging. Ann Clin Transl Neurol 2015; 2: 688–698.
151. Viboolvorakul S, Patumraj S. Exercise training could improve age-related changes in cerebral blood flow and capillary vascularity through the upregulation of VEGF and eNOS. Biomed Res Int 2014; 2014: 1–12.
152. Lucas SJ, Ainslie PN, Murrell CJ. Effect of age on exercise-induced alterations in cognitive executive function: relationship to cerebral perfusion. Exp Gerontol 2012; 47: 541–551.
153. Austin BP, Nair VA, Meier TB. Effects of hypoperfusion in Alzheimer’s disease. J Alzheimer’s Dis 2011; 26(Suppl 3): 123–133.
154. Resnick N, Yahav H, Shay-Salit A. Fluid shear stress and the vascular endothelium: for better and for worse. Prog Biophys Mol Biol 2003; 81: 177–199.
155. Rinholm JE, Hamilton NB, Kessaris N. Regulation of oligodendrocyte development and myelination by glucose and lactate. J Neurosci 2011; 31: 538–548.
156. Nave KA, Werner HB. Myelination of the nervous system: mechanisms and functions. Annu Rev Cell Dev Biol 2014; 30: 503–533.
157. Ghiani CA, Ying Z, de Vellis J. Exercise decreases myelin-associated glycoprotein expression in the spinal cord and positively modulates neuronal growth. Glia 2007; 55: 966–975.
158. Di Marco LY, Venneri A, Farkas E. Vascular dysfunction in the pathogenesis of Alzheimer’s disease – a review of endothelium-mediated mechanisms and ensuing vicious circles. Neurobiol Dis 2015; 82: 593–606.
159. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87: 315–424.
160. Chen BR, Kozberg MG, Bouchard MB. A critical role for the vascular endothelium in functional neurovascular coupling in the brain. J Am Heart Assoc 2014; 3: e000787.